CABALETTA BIO, INC. Basic Shares Outstanding (Weighted Average)
CABALETTA BIO, INC. (CABA) reported Basic Shares Outstanding (Weighted Average) of 151.16 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-13
- CABALETTA BIO, INC. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 151.16M shares, a 144.29% increase year-over-year.
- CABALETTA BIO, INC. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 112.03M shares, a 120.77% increase year-over-year.
- CABALETTA BIO, INC. weighted average number of shares outstanding, basic for the quarter ending 2025-06-30 was 61.88M shares, a 5197.41% increase year-over-year.
- CABALETTA BIO, INC. weighted average number of shares outstanding, basic for the quarter ending 2025-03-31 was 50.74M shares, a 4244.24% increase year-over-year.
- CABALETTA BIO, INC. weighted average number of shares outstanding, basic for fiscal 2023 was 1.17M shares, a 80.34% decline from fiscal 2022.
- CABALETTA BIO, INC. weighted average number of shares outstanding, basic for fiscal 2022 was 5.94M shares.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | 151.16M shares 10-Q · filed 2026-08-13 | 131.70M shares 10-Q · filed 2026-08-13 | ||
| 2026-03-31 | 112.03M shares 10-Q · filed 2026-05-14 | |||
| 2025-06-30 | 61.88M shares 10-Q · filed 2026-08-13 | 56.34M shares 10-Q · filed 2026-08-13 | ||
| 2025-03-31 | 50.74M shares 10-Q · filed 2026-05-14 | |||
| 2024-09-30 | -462.39K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | 352.83K shares derived: average of 2 quarters · filed 2024-11-14 | 624.57K shares 10-Q · filed 2024-11-14 | -122.71K shares derived: average of 4 quarters · filed 2025-03-31 |
| 2024-06-30 | 1.17M shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | 1.17M shares 10-Q · filed 2024-08-08 | -9.48K shares derived: average of 3 quarters · filed 2025-03-31 | -313.14K shares derived: average of 4 quarters · filed 2025-03-31 |
| 2024-03-31 | 1.17M shares 10-Q · filed 2024-05-15 | -598.25K shares derived: average of 2 quarters · filed 2025-03-31 | -806.87K shares derived: average of 3 quarters · filed 2025-03-31 | 427.46K shares derived: average of 4 quarters · filed 2025-03-31 |
| 2023-12-31 | -2.36M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | -1.79M shares derived: average of 2 quarters · filed 2025-03-31 | 180.59K shares derived: average of 3 quarters · filed 2025-03-31 | 1.17M shares 10-K · filed 2025-03-31 |
| 2023-09-30 | -1.22M shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | 1.45M shares derived: average of 2 quarters · filed 2024-11-14 | 2.35M shares 10-Q · filed 2024-11-14 | |
| 2023-06-30 | 4.13M shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | 4.13M shares 10-Q · filed 2024-08-08 | ||
| 2023-03-31 | 4.13M shares 10-Q · filed 2024-05-15 | |||
| 2022-12-31 | 5.94M shares 10-K · filed 2024-03-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Artiva Biotherapeutics, Inc. (ARTV) | United States | $0.367B | |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |
| Ocugen, Inc. (OCGN) | United States | $0.343B | -6.34 |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Century Therapeutics, Inc. (IPSC) | United States | $0.306B | -4.02 |